Ledger.Open graph →

SEC Form D · Amendment · filed October 31, 2016

CURE PHARMACEUTICAL Corp

Offering

$2.0M

Sold

$2.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

OXNARD, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Wayne Nasby · Oxnard, CADirector Ed Maliski · Oxnard, CADirector Mark Udell · Oxnard, CAExec Ian Sephton · Oxnard, CADirector Rob Davidson · Oxnard, CAExec · Director Vic Branstetter · Oxnard, CADirector Carle D. Stenmark · San Francisco, CADirector Andrew Lerner · New York, NYExec · Director Patrick Hutchines · Luxembourg, LuxembourgExec Vic Branstetter · Oxnard, CADirector Alex Maffeo · New York, NYDirector Luke Ledbetter · New York, NYDirector Bob Glosson · Durham, NCExec · Director Barry Boniface · Durham, NCDirector Jerry Nowlin · Durham, NCDirector Mark Feidler · Durham, NCDirector Jack Barry · Durham, NCExec John L. King, Jr · Fort Worth, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗